- In August 2022, Orthopedic surgeons at NHS Golden Jubilee performed the first meniscal transplant in Scotland at the University National Hospital, which handles over 25% of Scotland’s hip and knee replacements. The innovative keyhole procedure involved implanting donor cartilage from a deceased donor in the U.S., offering a potential solution for patients with persistent knee pain
- In June 2022, Isto Biologics launched the Influx Fibrant line, an advanced series of 100% cortical allograft constructs, including products like Fibrant Anchor, Boat, Bullet, Pak, and Wrap. This launch featured patented technology from Isto's acquisition of TheraCell, enhancing orthopedic allograft offerings for spinal fusion and other applications
- In February 2024 , Tetrous, Inc. launched the EnFix TAC to complement the EnFix RC, offering a 100% demineralized bone allograft implant line designed to enhance healing at the bone-to-tendon interface in rotator cuff surgery. The product, supported by strong preclinical data, provides flexibility for surgeons and shows promising clinical results
